Efficacy and Safety of Auto-FMT in Preventing aGVHD | MicrobiomeTrials← Back to trialsNCT04745221
Efficacy and Safety of Auto-FMT in Preventing aGVHD
CompletedNAINTERVENTIONAL
Trial Details
Start: 2021-08-27Est. Completion: 2025-08-27
Enrollment target: 105 participants Locations- First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Other microbiome trials you might be interested in
Sickle Cell Disease
Background:
Sickle Cell Disease (SCD) is a blood disorder that occurs mainly in people of African descent. Researchers …
Bethesda, United StatesCompleted Dec 9, 2019
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Pediatric AML
R/R AML
R/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple LocationsEst. completion Apr 30, 2030
DementiaAgitationBehavioural and Psychological Symptoms of DementiaMajor Neurocognitive DisorderAgitation Aggression in Dementia
The goal of this feasibility clinical trial is to learn whether supervised virtual reality (VR) sessions can be safely a…
London, CanadaEst. completion Dec 30, 2027